Welcome to My Meds Matter

IACP files comments for FDA's insanitary conditions at compounding facilities draft guidance

It is essential that FDA adheres to the plain language of statutes.

The current draft guidance fails to follow Congressional intent, current State laws or regulations and USP General Chapters <795> and <797> as it pertains to pharmaceutical compounding.

ASHP Urges FDA to Make Changes to Compounding Guidances Released in April 2016

ASHP submitted comments strongly urging FDA to make revisions

ASHP submitted comments strongly urging FDA to make revisions to the three draft compounding guidances published in April 2016. Compounding regulation has long been a priority issue for ASHP.ASHP submitted comments strongly urging FDA to make revisions to

Protect access to critical medications

AVMA Pushes FDA to Protect Ketamine Availability

Calls for Members to Comment to FDA

The AVMA has submitted formal comments asking the U.S. Food and Drug Administration to work to protect veterinarians’ ability to continue using ketamine as needed to treat patients

House Committee Says FDA's Compounding Policies are Overreach

Committee Demands Radical Policy Revisions

House Appropriations Committee says FDA policies go against Congressional intent

Senator David Vitter (R-LA)

Saving Access to Compounded Medications for Special Needs Patients Act

Addresses confusion over a compounding pharmacy’s “distribution” of compounded preparations

Senator David Vitter (R-LA) introduced S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act

FDA

FDA releases draft guidance on animal drug compounding

Proposed policy lays out new rules for veterinarians

The U.S. Food and Drug Administration has made good on a decade-old promise to provide updated guidance on the regulatory complexities of compounding animal drugs from bulk substances.

Urgent

Act today to save your compounded medication!

Access to compounded medications is once again at risk because of the FDA.

Your access to compounded medications is once again at risk because of the Food and Drug Administration (FDA). Help us protect your rights and add your comments to those of physicians and patients nationwide who are telling FDA to play by the rules Congre

No front page content has been created yet.